PI3K/AKT/mTOR signaling pathway and targeted inhibitors
PI3K/AKT/mTOR signaling pathway and targeted inhibitors. Dysregulation of PI3K/AKT/mTOR signaling enhances the Warburg effect in tumors, promotes cell proliferation and metastasis in HCC. In addition, we describe the latest clinical trials of inhibitors targeting the PI3K/AKT/mTOR pathway. 4EBP1, eukaryotic translation initiation factor 4E‐binding protein 1; BAD, bcl‐2 agonist of cell death; ERBB2, human epidermal growth factor receptor‐2; FOXO1, Forkhead box O1; GSK‐3β, glycogen synthetase kinase‐3beta; MET, mesenchymal epithelial transfer factor; mTOR, mammalian target of rapamycin; PIP2, phosphatidylinositol‐4,5‐diphosphate; PIP3, phosphatidylinositol‐3,4,5‐diphosphate; PTEN, phosphatase and tensin homolog; PI3K, phosphoinositide 3‐kinase; RET, rearranged during transfection; S6K, S6 kinase; SREBP, sterol regulatory element binding protein; SRPK2, arginine protein kinase 2; TSC, tuberous sclerosis complex
Publication
Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy (2024) Xiaoting Luo, et al. MedComm (2020). 2024 Feb;5(2). Figure: F3.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | ERBB2 | ERBB2 | ncbigene_symbol | ERBB2 | 2064 |
| Homo sapiens | Primates | EGFR | EGFR | ncbigene_symbol | EGFR | 1956 |
| Homo sapiens | Primates | VEGFR | VEGFR | ncbigene_synonym | KDR | 3791 |
| Homo sapiens | Primates | VEGFR | VEGFR | famplex_relations | FLT1 | 2321 |
| Homo sapiens | Primates | VEGFR | VEGFR | famplex_relations | FLT4 | 2324 |
| Homo sapiens | Primates | RET | RET | ncbigene_symbol | RET | 5979 |
| Homo sapiens | Primates | PDK1 | PDK1 | ncbigene_symbol | PDK1 | 5163 |
| Homo sapiens | Primates | PDK1 | PDK1 | ncbigene_synonym | PDPK1 | 5170 |
| Homo sapiens | Primates | AKT | AKT | ncbigene_synonym | AKT1 | 207 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT2 | 208 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT3 | 10000 |
| Homo sapiens | Primates | PTEN | PTEN | ncbigene_symbol | PTEN | 5728 |
| Homo sapiens | Primates | p85 | P85 | ncbigene_synonym | PIK3R1 | 5295 |
| Homo sapiens | Primates | p85 | P85 | ncbigene_synonym | PIK3R2 | 5296 |
| Homo sapiens | Primates | p85 | P85 | ncbigene_synonym | ARHGEF7 | 8874 |
| Homo sapiens | Primates | p85 | P85 | ncbigene_synonym | CBFA2T2 | 9139 |
| Homo sapiens | Primates | p85 | P85 | ncbigene_synonym | PPP1R13B | 23368 |
| Homo sapiens | Primates | p85 | P85 | ncbigene_synonym | PPP1R12C | 54776 |
| Homo sapiens | Primates | p110 | P110 | ncbigene_synonym | CUX1 | 1523 |
| Homo sapiens | Primates | p110 | P110 | ncbigene_synonym | SART3 | 9733 |
| Homo sapiens | Primates | mTORC2 | MTORC2 | famplex_relations | MAPKAP1 | 79109 |
| Homo sapiens | Primates | mTORC2 | MTORC2 | famplex_relations | MTOR | 2475 |
| Homo sapiens | Primates | mTORC2 | MTORC2 | famplex_relations | RICTOR | 253260 |
| Homo sapiens | Primates | mTORC2 | MTORC2 | famplex_relations | MLST8 | 64223 |
| Homo sapiens | Primates | TSC2 | TSC2 | ncbigene_symbol | TSC2 | 7249 |
| Homo sapiens | Primates | mTORC1 | MTORC1 | famplex_relations | RPTOR | 57521 |
| Homo sapiens | Primates | TSC1 | TSC1 | ncbigene_symbol | TSC1 | 7248 |
| Homo sapiens | Primates | TSC1 | TSC1 | ncbigene_synonym | CCL26 | 10344 |
| Homo sapiens | Primates | GSK3B | GSK3B | ncbigene_symbol | GSK3B | 2932 |
| Homo sapiens | Primates | 4EBP1 | 4EBP1 | ncbigene_synonym | EIF4EBP1 | 1978 |
| Homo sapiens | Primates | S6K | S6K | ncbigene_synonym | RPS6KB1 | 6198 |
| Homo sapiens | Primates | BAD | BAD | ncbigene_symbol | BAD | 572 |
| Homo sapiens | Primates | SRPK2 | SRPK2 | ncbigene_symbol | SRPK2 | 6733 |
| Homo sapiens | Primates | FOXO1 | FOXO1 | ncbigene_symbol | FOXO1 | 2308 |
| Homo sapiens | Primates | cyclinD1 | CCND1 | ncbigene_symbol | CCND1 | 595 |
| Homo sapiens | Primates | HIF-1a | HIF-1A | ncbigene_synonym | HIF1A | 3091 |
| Homo sapiens | Primates | c-myc | C-MYC | ncbigene_synonym | MYC | 4609 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| MET | Met | methionine | chebi:16811 | |
| Rapamycin | rapamycin | (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone | chebi:9168 | |
| Copanlisib | copanlisib | 2-amino-N-{7-methoxy-8-[3-(morpholin-4-yl)propoxy]-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl}pyrimidine-5-carboxamide | chebi:173077 | |
| Nucleus | nucleus | nucleus | chebi:33252 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|